Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Make way for MiniMed! Medtronic's diabetes division has filed the necessary paperwork to go public. The company hopes to be traded on Nasdaq under the symbol MMED.
The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy."
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
The American Association of Physicists in Medicine issued a statement this week saying radiation harm from typical imaging devices virtually doesn’t exist.
A leading national radiology network just got even bigger. vRad Radiology Alliance announced that seven physicians from Montgomery Radiology Associates joined its Pennsylvania partner, Diagnostic Imaging Inc.
The American College of Radiology announced that Jeffrey Immelt, General Electric chairman, will keynote the inaugural event for the Radiology Leadership Institute in July.
Uncertainty remains over how much money physicians can expect to get paid from Medicare next year as Congress fails to reach agreement on an omnibus spending bill that includes a temporary freeze on physician reimbursements.